Latest filing published 27 Apr 2023 for Cardiovascular Systems Inc, €2.0M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alexander Rosenstein: trading record in brief
Alexander Rosenstein (senior executive) discloses dealings in Cardiovascular Systems Inc to SEC (Form 4). Between 8 August 2016 and 27 April 2023, the trades on record add up to 45 filings.
Every open-market trade on record is a sale: 13 sales worth €727k. Besides market trades, the filings include 24 share grants.
The newest entry dates from 27 April 2023: a transaction of €743k, in Cardiovascular Systems Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alexander Rosenstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 107,700 shares@ US$20.0090.5% of flowCommon StockSEC:0001062993-23-009594:0
- 984 shares@ US$19.700.8% of flowCommon StockSEC:0001062993-23-003444:0
- 10,955 shares0Common StockSEC:0001437749-22-021195:0
- 2,601 shares@ US$16.641.9% of flowCommon StockSEC:0001437749-22-020767:0
- 14,347 shares0Common StockSEC:0001437749-22-019618:0
- 5,477 shares0Common StockSEC:0001437749-22-002878:0
- 681 shares@ US$35.381.0% of flowCommon StockSEC:0000914190-21-000316:0
- 4,125 shares0Common StockSEC:0000914190-21-000301:0
- 1,685 shares@ US$36.072.5% of flowCommon StockSEC:0000914190-21-000268:0
- 5,576 shares0Common StockSEC:0000914190-21-000238:0
10 of 10 declarations
